Biotest GmbH & Co KGaA - Company Profile
Powered by 
All the sales intelligence you need on Biotest GmbH & Co KGaA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Biotest GmbH & Co KGaA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Biotest GmbH & Co KGaA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Biotest GmbH & Co KGaA (Biotest), a subsidiary of Grifols SA, develops, manufactures, and distributes biological medicines. The company’s vertically integrated operations, focus on R&D, and strong product portfolio are its strengths, even as financial performance could be a cause for concern for the company. Biotest could benefit from the market potential for acute myeloid leukemia (AML), the launch of new products, and regulatory approvals. However, intense competition, government regulations, and stringent pricing pressures in the US could affect its financial performance.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer